Tag: Myocardial infarction

First-in-human Trial of CRISPR Gene-editing ANGPTL3 Safely Lowered Cholesterol and Triglycerides

Key Points: CTX310 is a first-in-class in vivo CRISPR-Cas9 therapy designed to…

Basir Gill

DAPT-MVD: Extended DAPT reduces MACCE in patients with multi-vessel disease after DES

Key Points: The optimal duration and choice of dual antiplatelet therapy (DAPT)…

Basir Gill

NOAC Monotherapy Non-Inferior to Combination Therapy for Net Adverse Clinical events in AF Patients Post–DES: ADAPT AF-DES Trial

Key Points The ADAPT AF-DES randomized trial compared NOAC monotherapy (apixaban or…

Basir Gill

Prasugrel Might be a Better Choice than Ticagrelor For DAPT after PCI for Patients with Diabetes and MVD: The TUXEDO-2 Trial

Key Points TUXEDO-2 directly compared ticagrelor vs prasugrel based DAPT in 1,800…

Basir Gill

CorCMR: Stress Cardiac MRI Uncovers Hidden Angina and Improves Quality of Life in Patients Without Obstructive Coronary Disease

Key Points: Stress cardiac MRI (CMR) enhanced diagnostic accuracy for patients with…

Basir Gill

CELEBRATE: Early Pre-hospital Subcutaneous Zalunfiban Improves Coronary Patency and Outcomes in STEMI Without Increasing Severe Bleeding

Key Points: Early pre-hospital administration of subcutaneous zalunfiban improved coronary patency and…

Basir Gill

Atorvastatin Reduced Left Ventricular Dysfunction From Anthracyclines: The STOP-CA Trial

  Key Points -Anthracycline therapy is associated with the development of heart…

Leah Kosyakovsky

Influenza Vaccination after Myocardial Infarction Should Become Standard of Care – Results of the IAMI Trial

Key Points: Prior observational and small randomized studies suggested that influenza vaccine…

Wally Omar

SMART-MI shows Benefits of Cardiac Monitoring after Myocardial Infarction

KEY POINTS: Implantable Cardioverter Defibrillators (ICDs) are indicated for post-myocardial infarction patients…

Wally Omar